affects millions of people that travel to third world countries
every year. It develops after ingestion of contaminated food or
water. While it is rarely fatal and generally clears on its own,
people affected by it will generally spend a day or two in bed.
They will need to cut back their activities. It can also cause
more serious illnesses in children and pregnant women. A
clinical trial was conducted to study the effectiveness and
risks of a potential vaccine, heat-labile toxins from (LT). The
study, published in the , showed positive results in reducing
the incidence or duration of traveler’s diarrhea. About the
Study The study followed 201 healthy adults 18-64 years of age
planning a trip to Mexico or Guatamala from the US. The
participants were randomly assigned to one of two groups: -
Group 1 received two patches with 37.5 mug of LT - Group 2
received two patches with a placebo The patches were given 2-3
weeks before travel. The travelers tracked stool output and
provided stool samples if diarrhea occur